HO-PEG17-OH

Catalog No.: C007B-583858
Mfr. No.: P595571-50mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $190.21

List Price: $211.35

PEG18 contains repeating ethylene glycol subunits and two terminal hydroxyl groups. The hydroxyl groups can participate in reactions to further derivatize the compound.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

PEG18 contains repeating ethylene glycol subunits and two terminal hydroxyl groups. The hydroxyl groups can participate in reactions to further derivatize the compound. The hydrophilic PEG chain increases the water solubility of the compound in aqueous media. The water solubility properties of the PEG linker are enhanced with longer PEG chains. HO-PEG17-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Specifictaions: ≥97%

MDL Number: C34H70O18

Molecular Formula: 766.91

PubChem CID: 13956225

Isomeric SMILES: C(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)O

UPC:: 42321506
Condition:: New
Availability:: 4-8 weeks
Weight:: 1.06 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: P595571-50mg
CAS:: 351342-04-6
Product Size:: 50mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."